At the ECR 2011, Sectra invited four mammography experts to share their views on “how new technology can improve cancer detection while lowering radiation.” This second edition of the symposium first held in 2010 was very well attended and confirmed the interest in these new technologies.
The recorded version of the symposium is now available for …
Breast cancer screening programmes are helping to reduce the mortality rates of women by finding cancer in its early stages when it is easier to treat. Sweden was one of the first countries in the world to introduce a screening program after succesful clinical trials in the 1980s. However x-ray radiation is also a risk factor for inducing breast cancer, …
At ECR, four experts shared their views on the challenges of early cancer detection. The recorded version of this very interesting and well attended symposium is now available for you to watch and share with your colleagues.
Why do we miss cancers in mammography: What the DMIST trial tells us
Martin Yaffe, Professor, Toronto, Canada…
The mammography symposium held at ECR on March 6 attracted a large and highly qualified audience, all interested in how to improve cancer detection in mammography.
Photos of the speakers:
Photos from the event:
Link …
Region Zealand in Denmark has decided to offer female citizens mammography screening within 30 km of their homes. It is natural to assume, but yet to be proven, that participation rates improve if women need to spend less time on transportation when attending a screening examination. Region Zealand has a very high participation rate of …
Digitization of the imaging procedure was a great leap forward, particularly in terms of workflow and dose efficiency. Although screening programs are proven to decrease breast cancer mortality by up to 45%, we still miss 30% of cancers. Also, high recall rates are a frequent source of debate. In short, there is still room for …
When King Edward VII’s Hospital Sister Agnes, London, installed Sectra MicroDose Mammography in October 2008, staff were optimistic that this new investment would not only offer more attractive screening to women, but efficiency would improve, too. They were not disappointed: MicroDose has provided the Hospital with a clear differentiator, and patient throughput has doubled.
Great marketing …
Breast cancer then and now
Breast cancer is the most common disease affecting women. It accounts for more than 30% of all cancers affecting women, far ahead of colon, ovary or lung cancer.
However, breast cancer is responsible for only 1% of cancer-related deaths. In countries with effective screening programs, more than 90% of women diagnosed with …
AuntMinnie.com Headlines